This Is Why Ocular Therapeutix Inc.’s Stock Hit the Ceiling Today – July 11, 2017
A few days ago, shares of biopharmaceutical startup Ocular Therapeutix (NASDAQ:$OCUL) were plummeting — but on July 11, the company’s shares shot up by 26%. This is largely due to the fact that Ocular Therapeutix …
Arena Pharmaceutical Inc.’s Shares Sees New Heights After Positive Results of Drug Study
Shares of Arena Pharmaceuticals Inc. (NASDAQ:$ARNA), a company that works on developing and commercializing a number of biopharmaceutical products, went up by 35% late in the day of July 10, 2017. The rise can largely …
This is Why Shares of Ocular Therapeutix Inc. Spiraled Today – July 7, 2017
As of around 4:50 PM EDT on July 7, 2017, Ocular Therapeutix Inc.’s (NASDAQ:$OCUL) stocks have fallen by 25.05% to $7.12 from its $9.05 opening this morning. The dramatic fall occurred after Adam Feuerstein at …
This is Why BeiGene Ltd.’s Shares Rose Significantly on July 6, 2017
At one point on the morning of July 7, 2017, biopharma company BeiGene Ltd.’s shares (NASDAQ:$BGNE) went up as high as 31%. The rise in prices came shortly after the company announced a partnership with …
Celsion Corp’s Stock Increased Almost 25% Today
On Wednesday, July 5, in a morning trading session, shares of Celsion Corp. (NASDAQ:$CLSN) increased almost 25% to $2.53. This jump occurred after the New Jersey-based firm disclosed the completion of the Ovation study, a …
A British Biotech Company is Close to a Breakthrough Blood Test for Diagnosing Ovarian Cancer
On Monday, U.K-based biotech company Angle plc (OTCQX:$ANPCY) disclosed the trial results of a possible breakthrough blood test for diagnosing ovarian cancer.
Essentially, Angle’s blood test could allow for a quicker diagnosis and …
Should You Invest in Conatus Pharmaceuticals Inc.?
Conatus Pharmaceuticals Inc. (NASDAQ:$CNAT), a biotech-pharmaceutical company focused on developing drugs to treat liver disease, has been seeing quite a rise in its stocks recently. This can be largely due to the company’s announcement a …
Mutual Fund Schemes Invested in Pharma Companies Outperform Large Markets
There are numerous mutual funds categories and each allows prospective investors to choose a scheme based on a variety of factors, including the amount of risk that they want to take and the investment term. …
Epizyme Stock Rises with Positive Media Coverage, According to Analysis
Media coverage of biopharmaceutical company Epizyme (NASDAQ:$EPZM) has been pretty positive recently, according to research group Alpha One Sentiment Analysis. Alpha One helps company identify positive and/or negative media coverage through the analysis of more …
RedHill Biopharma Ltd – ADR Stock Rises After Positive Phase III Results of BEKINDA Treatment
Israel-based biopharmaceutical company RedHill Biopharma Ltd – ADR (NASDAQ:$RDHL) saw its stocks rise after the company’s release of the results from its Phase III clinical trial named GUARD. GUARD tested the performance of using RHB-102 …